VPC-16606 is a selective inhibitor targeting the activation function 2 (AF2) domain of estrogen receptor alpha (ERalpha). VPC-16606 blocks the interaction between ERalpha and coactivators, inhibits the activity of both wild-type and clinically drug-resistant mutant ERalpha, and exerts inhibitory effects on hormone-resistant breast cancer cells. VPC-16606 can be used in breast cancer research[1].
Molecular Weight:
344.81
CAS Number:
[2027540-49-2]
Formula:
C17H13ClN2O2S
Target:
Estrogen Receptor/ERR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
